Coronary atherosclerosis severity is significantly associated with decreased renal function, according to researchers.

Adverse clinical outcomes associated with a given level of estimated glomerular filtration rate (eGFR) vary substantially based on the presence and severity of proteinuria, according to Canadian researchers.

Nephrologists propose critical action eGFR thresholds to guide management of kidney disease patients.

Two or more servings per day found to double the risk of a 30% or greater decline in eGFR.

Albuminuria is strongly associated with the severity of calcified atherosclerotic plaque (CP) in white but not black individuals with type 2 diabetes, according to a new study.

Although abnormal calcium levels have been linked to an increased chance of premature death in dialysis patients, new research indicates a similar risk for people in earlier stages of CKD.

Diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD among individuals who have had kidney stones, researchers reported in the American Journal of Kidney Diseases (2009; published online ahead of print).

Lovastatin may prevent development of cardiovascular disease (CVD) in CKD patients, according to study findings published in the American Journal of Kidney Diseases (2009; published online ahead of print).

Plasma copeptin, a marker of endogenous vasopressin levels, is associated with microalbuminuria, independent of age and other potential confounders, according to study findings published in Kidney International (2010;77:29-36).

BMI is a standard parameter in all clinical settings—both inpatient and outpatient. It is used in the pediatric population, in young and older adults, and in the chronically ill as a marker of health.